Core Insights - On November 3, Jianerkang's stock rose by 0.28% with a trading volume of 14.6064 million yuan, while the financing data indicated a net financing outflow of 58,700 yuan for the day [1] - As of November 3, the total margin balance for Jianerkang was 65.6223 million yuan, with the financing balance accounting for 5.92% of the circulating market value [1] - Jianerkang specializes in the research, production, and sales of disposable medical devices and disinfectant sanitary products, with its main revenue sources being nursing products (33.19%), surgical consumables (30.64%), polymer and auxiliary products (18.46%), and disinfecting cleaning products (16.93%) [1] Financial Performance - As of September 30, Jianerkang reported a total revenue of 725 million yuan for the first nine months of 2025, reflecting a year-on-year decrease of 7.35%, while the net profit attributable to shareholders was 76.4096 million yuan, down 18.24% year-on-year [2] - The number of shareholders decreased by 6.15% to 17,100, while the average circulating shares per person increased by 38.51% to 2,286 shares [2] Shareholder and Dividend Information - Since its A-share listing, Jianerkang has distributed a total of 42.12 million yuan in dividends [3] - As of September 30, 2025, the largest circulating shareholder among the top ten was the Medical Device ETF (159883), which holds 285,100 shares as a new shareholder [3]
健尔康11月3日获融资买入125.90万元，融资余额6561.95万元